Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality:results of a nationwide Dutch clinical audit by Kuhrij, Laurien S. et al.
 
 
 University of Groningen
Determinants of extended door-to-needle time in acute ischemic stroke and its influence on
in-hospital mortality
Kuhrij, Laurien S.; Marang-van de Mheen, Perla J.; van den Berg-Vos, Renske M.; de Leeuw,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kuhrij, L. S., Marang-van de Mheen, P. J., van den Berg-Vos, R. M., de Leeuw, F-E., Nederkoorn, P. J., &
Dutch Acute Stroke Audit consortium (2019). Determinants of extended door-to-needle time in acute
ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit. BMC
NEUROLOGY, 19(1), [265]. https://doi.org/10.1186/s12883-019-1512-2
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
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Determinants of extended door-to-needle
time in acute ischemic stroke and its
influence on in-hospital mortality: results of
a nationwide Dutch clinical audit
Laurien S. Kuhrij1,2*, Perla J. Marang-van de Mheen3, Renske M. van den Berg-Vos4, Frank-Erik de Leeuw5,6,
Paul J. Nederkoorn1 and on behalf of the Dutch Acute Stroke Audit consortium
Abstract
Background: Intravenous thrombolysis (IVT) plays a prominent role in the treatment of acute ischemic stroke (AIS).
The sooner IVT is administered, the higher the odds of a good outcome. Therefore, registering the in-hospital time
to treatment with IVT, i.e. the door-to-needle time (DNT), is a powerful way to measure quality improvement. The
aim of this study was to identify determinants that are associated with extended DNT.
Methods: Patients receiving IVT in 2015 and 2016 registered in the Dutch Acute Stroke Audit were included. DNT
and onset-to-door time (ODT) were dichotomized using the median (i.e. extended DNT) and the 90th percentile
(i.e. severely extended DNT). Logistic regression was performed to identify determinants associated with (severely)
extended DNT/ODT and its effect on in-hospital mortality. A linear model with natural spline was used to investigate
the association between ODT and DNT.
Results: Included were 9518 IVT treated patients from 75 hospitals. Median DNT was 26min (IQR 20–37). Determinants
associated with a higher likelihood of extended DNT were female sex (OR 1.17, 95% CI 1.05–1.31) and admission during
off-hours (OR 1.12, 95% CI 1.01–1.25). Short ODT correlated with longer DNT, whereas longer ODT correlated with
shorter DNT. Young age (OR 1.38, 95% CI 1.07–1.76) and admission to a comprehensive stroke center (OR 1.26, 1.10–
1.45) were associated with severely extended DNT, which was associated with in-hospital mortality (OR 1.54, 95%CI
1.19–1.98).
Conclusions: Even though DNT in the Netherlands is short compared to other countries, lowering the DNT may be
achievable by focusing on specific subgroups.
Keywords: Stroke, Intravenous thrombolysis, Quality improvement
Background
Stroke is one of the leading causes of disability and mor-
tality in the world [1]. Intravenous thrombolysis (IVT)
with recombinant tissue plasminogen activator (rtPA) is
an established intervention for patients with acute ische-
mic stroke (AIS). IVT increases the odds of independent
functioning. With every minute the treatment is started
earlier, the higher the odds of a good outcome: ‘time is
brain’ [2]. When IVT is administered within 90min after
onset of symptoms, the number needed to treat (NNT)
is 4.5 which is increased to a NNT of 9 between 91 and
180 min [3]. The door-to-needle time (DNT), the time
from presentation of patient with symptoms at the hos-
pital to the start of IVT, can therefore be used to evaluate
the quality of the acute stroke care provided by each hos-
pital [4]. Lowering the median DNT is an essential goal
for quality improvement and is therefore used worldwide
in audits for this particular purpose.
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In the Netherlands, the Dutch Acute Stroke Audit
(DASA) registers the median DNT as a process indicator
to allow for comparison between hospitals. The median
DNT is relatively short in the Netherlands compared to
other countries [5]. Given that reduction in time to treat-
ment increases the probability of a good outcome, it re-
mains crucial to identify which patients have a longer than
median DNT. The aim of this study is to identify patient-
and clinical characteristics associated with (severely) ex-
tended DNT from a large nationwide registry. Secondary
objectives were to identify factors associated with a delay
in onset-to-door time (ODT) and to assess the impact of
extended DNT on in-hospital mortality.
Methods
Patients and data
The DASA is a nationwide, registry-based, prospective co-
hort study in which data are collected of patients with AIS
and hemorrhagic stroke admitted to one of the 81 hospitals
participating in the registry since 2014 [5]. The DASA is a
clinical audit managed by the Dutch Society of Neurology,
a nationwide professional association for neurologists, and
facilitated by the Dutch Institute for Clinical Auditing
(DICA). It utilizes indicators to measure the quality of care
and provides a national benchmark. For the present study,
all consecutive patients with AIS who received IVT regis-
tered in 2015 and 2016 in the DASA were included. At this
time, pre-notification by ambulance and computed tomog-
raphy (CT) of the brain as primary imaging modality was
considered standard of care. AIS was defined as infarction
proven on imaging with a deficit exceeding 24 h. Excluded
were patients with transient ischemic attack (TIA) or in-
farction as a complication of cerebral venous thrombosis.
Under Dutch law, no informed consent or ethical approval
was required for this study.
Definitions
DNT was defined as the difference between door-time
and needle-time. The definition of the door-time was
the time at which the patient was presented at the emer-
gency room with a stroke. In case the patient was
already admitted to the hospital, the time of examination
by the neurologist was used as the door-time. Needle-
time was defined as the time when the (bolus of) rtPA
was given. In 575 patients (5.4%) the DNT was unknown
and therefore these were excluded from the analysis. For
this study, two different cut-off points were used for
analysis: ‘extended DNT’ and ‘severely extended DNT’.
Extended DNT was defined as a DNT above the median,
as the median DNT is used as a quality indicator of
acute stroke care. Severely extended DNT was deter-
mined as a DNT above the 90th percentile. These cut-
off points were chosen for two purposes: to investigate
whether there is a difference in determinants associated
with both cut-off points and to compare these determi-
nants to studies in other countries where the cut-off
point was around an hour corresponding with the 90th
percentile of this study [6–8]. The upper limit of the
DNT is set to 270 min, consistent with the timeframe of
4.5 h in which the IVT is indicated. Similarly, the upper
limit of the ODT was set at 270 min.
ODT was defined as the difference between onset-time
and door-time. Onset-time was defined as the time when
signs and symptoms of stroke occurred, as reported by the
patient or an observer. In case the patient had a stroke
during sleep, or the patient could not recall the time when
symptoms began, the onset time was defined as unknown.
The ODT was unknown in 545 patients (5.3%). Therefore
these patients were excluded from the analysis. Similar to
the cut-off points for DNT, ODT cut-off points were set
at median (extended ODT) and the 90th percentile (se-
verely extended ODT). A comprehensive stroke center
was specified as a stroke center in which intra-arterial
thrombectomy can be performed following IVT. Primary
stroke centers are those performing IVT only.
Admission during off-hours was specified as admission
outside office hours from Monday until Friday, i.e. between
18:00 and 8:00 h, or on Saturday or Sunday. In-hospital
mortality was defined as death during admission at the
hospital.
Statistical analysis
First, we used descriptive statistics to test for differences
in patient characteristics, hospital factors as well as out-
comes between 2015 and 2016, given the known decrease
in DNT over time. ODT and DNT were reported as me-
dians with interquartile ranges (IQR). Chi-square tests
were used to test for differences in dichotomous variables.
Mann-Whitney U test and Kruskal-Wallis tests were used
to test for differences in age and ODT/ DNT respectively
as these factors were not normally distributed.
Secondly, we performed logistic regression analysis to
identify possible determinants for (severely) extended DNT
and (severely) extended ODT. Univariate and subsequently
multivariable logistic regression analysis was performed for
both outcomes. The following possible determinants for
extended or severely extended DNT were tested: age
(continuous, in years), sex (female/male), ODT (continuous,
in minutes), admission to comprehensive stroke center (yes
vs no), admission during off-hours (yes vs no) and year of
inclusion (2015 vs 2016). The determinants selected for
identification of determinants associated with (severely) ex-
tended ODT were similar to the DNT analysis. The severity
of signs and symptoms of the stroke (using a National Insti-
tute of Health Stroke Scale (NIHSS)-score) was not regis-
tered in the DASA during the study period. Continuous
variables were first plotted to check for possible non-
linearity. If so, points at which the relations changed were
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used to classify into categories. Factors with a p-value
of 0.1 or lower in univariate analysis were included in
the multivariable regression. Factors were added using
forward selection and interaction between factors was
investigated. The correlation between ODT and DNT
was further analyzed by a generalized linear model
using a natural spline. A heatmap was added to pro-
vide a graphical representation of data to visualize the
density of individual DNTs for each time point. In
this heatmap, the grey color indicates a low density
whereas the light blue indicates higher density.
Lastly, possible determinants associated with in-
hospital mortality were tested. Continuous variables (i.e.
age, ODT and DNT) were first plotted to check for non-
linearity and categorized by change in association. Simi-
lar logistic regression analysis was used to determine the
association between DNT and in-hospital mortality, ad-
justed for included determinants.
R studio version 3.4.3 was used for statistical analysis.
Results
In total, 55,860 patients with AIS from 75 Dutch hos-
pitals were registered in the DASA in 2015 and 2016.
Of these patients, 10,638 received IVT (19%). After
exclusion of patients with unknown ODT (n = 837)
and DNT (n = 575), 9518 could be included in the
current analyses (Table 1). The mean age was 71 years
and 54% were males. Median ODT was 71 min and
did not significantly change over the years. Thirty-two
percent of patients were admitted to a comprehensive
stroke center. The percentage of patients admitted
during off-hours did not change over time (p = 0.64).
Median DNT decreased from 27 min in 2015 to 25
min in 2016 (p < 0.001). In-hospital mortality in this
study group reduced from 6.2 to 5.6% although this
was not statistically significant (p = 0.29).
Factors influencing the door-to-needle time
Extended DNT was thus defined as DNT above 26 min
and severely extended DNT above 55 min. The impact
of different determinants on (severely) extended DNT
are shown in Table 2. Factors independently associated
with an increased likelihood of an extended DNT were:
female sex (OR 1.17, 95% CI 1.05–1.31), admission dur-
ing off-hours (OR 1.12, 95% CI 1.01–1.25) and inclusion
in 2015 versus 2016 (OR 1.33, 95% CI 1.14–1.35). An
ODT of three hours and above had a significantly re-
duced likelihood of an extended DNT (OR 0.75, 95% CI
0.61–0.91).
Factors that increased the likelihood on severely ex-
tended DNT were slightly different: age below 50 years
(OR 1.38, 95% CI 1.07–1.76), admission to comprehen-
sive stroke center (OR 1.26, 95% CI 1.04–1.50) and short
ODT (OR 1.37, 95% CI 1.11–1.69). Like with an ex-
tended DNT, an ODT of three hours and above was as-
sociated with a reduced likelihood of a severely extended
DNT (OR 0.46, 95% CI 0.28–0.56).
In Fig. 1, the correlation between ODT and DNT is visu-
alized. It appears that patients with a short ODT have a
higher DNT than patients with a long ODT. The median
DNT is 27 (IQR 20–40) in patients with an ODT of 40min
or shorter. Conversely, in patients with an ODT of three
hours or higher, the median DNT is 25 (IQR 18–33).
Factors influencing the onset-to-door time
Extended ODT was defined as ODT above 71 min and
severely extended ODT above 175 min. The following
factors were independently associated with extended
ODT: age above 75 years (OR 1.38, 95% CI 1.26–1.50),
female sex (OR 1.16, 95% CI 1.06–1.26) and admission
during off-hours (OR 1.12, 95% CI 1.03–1.21) (Table 3).
For severely extended ODT, these determinants were
similar with the addition of admission at a comprehen-
sive stroke center (OR 1.25, 95% CI 1.08–1.44).
Table 1 Baseline characteristics
Total 2015 2016 p-value
Number of patients 9518 4814 4704
Number of hospitals 75 75 74
Patient characteristics
Age in years (mean,sd) 71.0 (13.7) 70.9 (13.9) 71.0 (13.6) 0.77
Women (n, %) 4297 (46.0%) 2207 (46.4%) 2090 (45.5%) 0.39
Median onset-to-door time (IQR) 71.0 (45–119) 71.0 (45–119) 71.0 (45–119) 0.89
Hospital factors
Admission to comprehensive stroke center 3079 (32.3%) 1619 (33.6%) 1460 (31.0%) 0.01
Admission during off-hours 4696 (49.2%) 2358 (49.0%) 2328 (49.5%) 0.64
Median door-to-needle time (IQR) 26.0 (20–37) 27.0 (20–37) 25.0 (19–35) < 0.001
Outcome measure
In-hospital mortality 561 (5.9%) 296 (6.2%) 265 (5.6%) 0.29
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Table 2 Effect of patient- and clinical determinants on door-to-needle time, expressed in odds ratio’s (with 95th confidence
intervals) for different cut-off points
Door-to-needle time
Univariate analysis Multivariable analysis
Cut-off point in minutes Median 90th percentile Mediana 90th percentileb
26 55 26 55
Age (years)
< 50 1.19 (1.01–1.40)c 1.42 (1.11–1.81) c 1.16 (0.98–1.37) 1.38 (1.07–1.76) d
50–75 Reference
> 75 1.12 (0.98–1.27) 1.18 (0.95–1.45) 1.11 (0.97–1.27) 1.21 (0.97–1.49)
Female sex 1.21 (1.11–1.32) c 1.08 (0.94–1.24) 1.17 (1.05–1.31)d –
Onset-to-door time (minutes)
< 40 1.10 (0.99–1.23) 1.42 (1.20–1.66) c 1.15 (1.00–1.33) 1.37 (1.11–1.69) d
40–180 Reference
> 180 0.76 (0.65–0.88) c 0.40 (0.28–0.57) c 0.75 (0.61–0.91) d 0.46 (0.28–0.56) d
Admission to comprehensive stroke center 0.94 (0.86–1.03) 1.27 (1.10–1.46) c – 1.26 (1.04–1.50) d
Admission during off-hours 1.15 (1.06–1.25) c 1.08 (0.95–1.24) 1.12 (1.01–1.25) d –
Year of inclusion
2015 1.24 (1.14–1.34) c 0.97 (0.85–1.11) 1.33 (1.14–1.35) d –
2016 Reference
aAdjusted for age, female sex, onset-to-door time, admission during off-hours and year of inclusion. bAdjusted for age, onset-to-door time and admission to
comprehensive stroke center. cP-value below 0.1. dP-value below 0.05
Fig. 1 Association between onset-to-door time and door-to-needle time using a linear model with regression line and 95% CI. A heatmap
was added
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Effect of door-to-needle time on in-hospital mortality
Severely extended DNT (i.e. 55 min or higher) had a
higher odds of in-hospital mortality in patients receiving
IVT (OR 1.54, 95% CI 1.19–1.89) after adjustment for
other factors. Other factors increasing the in-hospital
mortality rate were age above 75 years (OR 3.45, 95% CI
2.86–4.19) and admission to comprehensive stroke cen-
ter (OR 1.39, 95% CI 1.56–1.66), as shown in Table 4.
Discussion
The present study has identified factors that are associated
with a higher DNT in this nationwide Dutch registry. Fe-
male sex and admission during off-hours were independ-
ently associated with a DNT above the overall median,
which was 26min. Age below 50 years, admission to a com-
prehensive stroke center and short ODT (ODT of 40min
or faster) were independently associated with a severely ex-
tended DNT (55min). A severely extended DNT was asso-
ciated with a higher likelihood of in-hospital mortality.
When comparing to international studies, the median
door-to-needle time in the Netherlands is a lot shorter
than in other countries [9–11]. In the present study, we
showed that the median DNT was 27min in 2015 which
was reduced to 25min in 2016 with a narrowing of the
distribution indicating that patients are not only treated
faster but also with less variability. Multiple explanations
can be provided for the already short and still decreasing
DNT. From 2008 the Dutch Society of Neurology, has
provided a national guideline for acute stroke treatment
that urged to implement a high-urgency stroke code, in-
cluding pre-arrival notification by paramedics, written
protocols of acute stroke care and ensuring availability of
imaging modalities before the arrival of the patient [12].
At the time of the study, the primary imaging modality was
computed tomography (CT). This high-urgency stroke
code is known to reduce DNT [13–16], and it has been im-
plemented throughout the Netherlands. Secondly, the me-
dian DNT for each hospital is made transparent yearly to
the public, healthcare institute and health care insurers, and
is used for benchmarking. This has encouraged the local
optimization of care to decrease DNT [17, 18].
One of the strengths of this study is that by using such a
large number of patients from a nationwide on-going
registry, we are able to identify factors to allow for further
improvement to establish an even shorter DNT. The fac-
tors identified in this study associated with extended DNT
were female sex and admission during off- hours. Earlier
studies have shown that females have a higher likelihood
of extended DNT than men [19]. The current hypothesis
is that women present with different neurological symp-
toms than men, such as pain and altered consciousness,
which has a wider differential diagnosis would make diag-
nosis more difficult [20], similar to the sex difference in
presention of acute coronary syndrome. More research
has to be done to explain this sex disparity. Admission
during off-hours is likely a delaying factor for IVT, imply-
ing that the acute stroke service is not as prompt during
off-hours, similar to which was found in several earlier
studies [8, 21]. This may be due to reduced staff or the
limited availability of resources. Alternatively there may be
an overrepresentation of severely affected patients during
off-hours as minor stroke patients may decide to wait until
the next day. In patients with severely extended DNT, age
below 50 years and admission to a comprehensive stroke
center were independently associated factors. In patients
below 50 years of age, there could be a higher prevalence
Table 3 Effect of patient- and clinical factors on onset-to-door time, expressed in odds ratio’s (with 95th confidence intervals) for
different cut-off points
Onset-to-door time
Univariate analysis Multivariable analysis
Cut-off point
in minutes
Median 90th percentile Mediana 90th percentileb
71 175 71 175
Age (years)
< 50 0.94 (0.80–1.10) 0.98 (0.73–1.28) 0.93 (0.80–1.10) 0.93 (0.69–1.23)
50–75 Reference
> 75 1.40 (1.29–1.52)c 1.29 (1.12–1.49) c 1.38 (1.26–1.50)d 1.27 (1.10–1.47) d
Female sex 1.23 (1.13–1.33) c 1.21 (1.05–1.39) c 1.16 (1.06–1.26) d 1.16 (1.01–1.33) d
Admission to comprehensive stroke center 0.98 (0.90–1.06) 1.27 (1.10–1.46) c – 1.25 (1.08–1.44) d
Admission during off-hours 1.11 (1.02–1.20) c 1.21 (1.05–1.38) c 1.12 (1.03–1.21) d 1.18 (1.03–1.36) d
Year of inclusion
2015 1.00 (0.92–1.08) 1.02 (0.89–1.17) – –
2016 Reference
aAdjusted for age, female sex and admission during off-hours. bAdjusted for age, female sex, admission to comprehensive stroke center and admission during off-
hours. cP-value below 0.1. dP-value below 0.05
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of stroke mimics making it more time consuming to make
the correct diagnosis. Comprehensive stroke centers are
more prone to receive the more severely affected and pos-
sibly complicated patients, which therefore could be an
explanation for the increased likelihood of severely ex-
tended DNT whereas it was not associated with extended
DNT. Another finding was that in patients whose ODT
was longer than three hours IVT has been administered
faster, which makes sense as IVT can otherwise not be
given as the timewindow for treatment is up to four
and a half hours. Additionally, physicians may take
more time for diagnosis in patients who present very
early after stroke onset. This finding is undesirable
because, as mentioned earlier, the sooner the patient is
treated, the higher the odds of a good outcome. Factors
associated with an extended ODT were age above 75
years, female sex and admission during off-hours. We
hypothesize that older patients are more often living
alone, especially in case of women surviving their male
partners, and that during off-hours patients are either
asleep, are reluctant to seek medical help in time or ex-
perience barriers in reaching out to medical assistance.
In severely extended ODT patients, admission to a
comprehensive stroke center was an additional factor.
We hypothesize that when a patient is almost outside
the time window for treatment with IVT but could
qualify for intra-arterial thrombectomy, they are pre-
sented in comprehensive stroke centers with a relatively
longer ODT due to longer travel time.
In patients with AIS treated with IVT, in-hospital mor-
tality decreased during the registry, although this was not
statistically significant. Severely extended DNT showed to
have a higher odds of death in these selected patients (OR
1.54), concurrent with the understanding that the earlier
IVT is administered, the better the outcome. However, an
alternative explanation could be that the medical status of
these patients was so severe that it was contemplated
whether these patients should receive IVT. ODT had no
statistically significant effect on in-hospital mortality, but
this could be due to the selection of patients that arrive at
the hospital in time and are therefore eligible for treat-
ment. Another factor associated with a higher in-hospital
mortality rate was admission to a comprehensive stroke
center. We believe that this could be explained by the fact
that in comprehensive stroke centers more patients with
more severe strokes will be presented which we could not
adjust for sufficiently. The NIHSS score, indicating the
severity of stroke, was in that period not yet registered in
the DASA in that period. In more recent years, the NIHSS
was added to the registry.
There are limitations to this study. Unmeasured clinical
factors could explain part of the relation between the de-
terminants and odds ratios of (severely) extended DNT.
Examples of these covariates not included in this study are
the NIHSS-score, other medical comorbidities (e.g. uncon-
trolled hypertension) and inpatients versus admitted at the
emergency room could impact DNT. The NIHSS-score
indicating the severity of stroke, could not be included as
Table 4 Effect of patient and clinical factors on in-hospital mortality
In-hospital mortality
Univariate analysis Multivariable analysis
OR(95%CI) p-value OR (95% CI) p-value
Age (years)
< 50 0.18 (0.06–0.43) < 0.01 0.17 (0.05–0.41) < 0.01
50–75 Reference
> 75 3.53 (2.90–4.31) < 0.01 3.45 (2.86–4.19) < 0.01
Female sex 1.33 (1.12–1.58) < 0.01 1.06 (0.89–1.27) 0.51
Admission to comprehensive stroke center 1.32 (1.10–1.57) < 0.01 1.39 (1.56–1.66) < 0.01
Admission during off-hours 1.09 (0.92–1.29) 0.34 – –
Year of inclusion




> = 180 0.88 (0.63–1.19) 0.42 – –
Door-to-needle time
< 55 Reference
> = 55a 1.48 (1.15–1.88) < 0.01 1.54 (1.19–1.98) < 0.01
aCorresponding with the 90th percentile
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previously mentioned. Other research has shown that pa-
tients with a lower NIHSS score have a higher DNT [22].
Before 2017, the NIHSS score was only registered as part
of trials, not on a national level and therefore was not
registered in the DASA at that time. We do believe that
admission at a comprehensive stroke center could be used
as a proxy as patients with more severe strokes are more
likely to be admitted to a comprehensive stroke center so
that we will have caputered part of the effect related to the
severity of stroke. However, in the absence of the NIHSS
score, we could not verify this.
Conclusions
This Dutch comprehensive stroke audit with real-world
data has identified factors that are independently associ-
ated with a (severely) extended DNT. Considering that a
reduction of time to treatment increases good outcome,
these factors are necessary to identify. Female patients
and patients admitted during off-hours have a higher
odds for a DNT above the median, i.e. 26 min. Young
patients and those admitted to a comprehensive stroke
center are more likely to have a DNT above the 90th
percentile, i.e. 55 min, and appear to have a higher in-
hospital mortality rate. Having identified these factors
and established its effect on in-hospital mortality, further
reduction of the DNT can be established by creating
awareness and focusing on these patient subgroups.
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